Reduce Stress and Anxiety After Cancer Treatment (RESTART)

Translational Research Program

RESTART Study

Are you an ovarian cancer patient who is interested in participating in a research study at Fred Hutch?

What is RESTART?

The RESTART Study is a pilot study to examine possible ways to reduce stress and anxiety for women who recently completed the first round of treatment for ovarian cancer. We are interested in learning if changing the heart rate rhythm will help a cancer patient think more positively. We hope to learn if this leads to a reduction in the levels of stress and anxiety that are experienced during the period following cancer treatment. The study uses a smartphone based heart rate device. 

The intervention includes techniques to help control emotions, relax, and reduce anxiety. This intervention, called the Heart Math Intervention, provides feedback through a take-home monitor that connects to a smartphone or iPhone. At the conclusion of the study the participant will keep the device to continue to use the techniques she learned during study participation.

file

If you are interested in participating, we invite you to call us at 1-800-732-4589.  Learn more about this research opportunity.

We are currently recruiting cancer patients who meet the following criteria:

  • Ages 18 – 80
  • Diagnosed with ovarian cancer
  • Completed your first round of treatment within the last 3-12 months
  • Own an IPhone or an Android phone
  • Willing to travel to Fred Hutch 2 times during your 12 weeks of study participation
  • Willing to participate in two fasting blood draws, one at each in-person session at Fred Hutch
  • Willing to receive up to five short check-in phone calls from the trainer

Other participant information:

  • Parking and breakfast are provided to participants.
  • Study participants will not be paid to participate in RESTART